kras mutation and glutathion glynac Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment Targeting KRAS mutations: orchestrating cancer
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges PMC Pancreatic Cancer: Advances and Challenges PMC Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Treatment of KRAS Mutated Pancreatic Cancer: New Hope for the Patients? Targeting mutated GTPase KRAS in tumor therapies ScienceDirect Acetyl CoA metabolism in cancer PMC
Pay in 4 interest-free payments of $7.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





